LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease.
Yong Wen LeowWah Loong ChanLee Lee LaiNik Raihan Nik MustaphaSanjiv MahadevaRonald QuiambaoMona MunteanuWah-Kheong ChanPublished in: Journal of gastroenterology and hepatology (2024)
LIVERSTAT had a higher negative predictive value compared with FIB4 and a lower misclassification rate compared with FIB4 when used in a two-step approach in combination with LSM for the diagnosis of advanced fibrosis.
Keyphrases